Weber Shandwick was honored with three 2014 CLIO Healthcare Awards for breakthrough healthcare campaigns executed in partnership with its clients. Now in its sixth year, the CLIO Healthcare Awards recognize the best in healthcare advertising, design and communications.
Weber Shandwick and its clients received the following honors:
- Silver CLIO Healthcare Award in the Health Services & Corporate Communications – Special Event category for “Birth of Biotech” with Genentech (Weber Shandwick U.S.)
- Bronze CLIO Healthcare Award in the Health Services & Corporate Communications – Corporate Image category for “Birth of Biotech” with Genentech (Weber Shandwick U.S.)
- Bronze CLIO Healthcare Award in the Disease Awareness – Apps category for “Set Your Sights” for wet-AMD education (Weber Shandwick U.S. & Europe)
“It’s an incredible thrill to be honored with such prestigious awards alongside our client partners,” said Laura Schoen, president of Weber Shandwick’s Global Healthcare practice. “Healthcare communications is truly a field where breakthrough creative ideas and innovative communications can change lives, and we’re proud to work in partnership with our clients to ignite these ideas, inspire new solutions, push creative boundaries and ultimately have a positive impact.”
Weber Shandwick’s Global Healthcare practice was named Healthcare Agency of the Year in 2013 by The Holmes Report. It was the first to become fully certified in both the U.S. and Europe in promotional regulatory compliance by the Center for Communication Compliance (CCC), reflecting the firm’s commitment to training and education, and understanding the highly complex regulated environment of health communication. It received recognition for the launch last year of Element Scientific Communications™, an industry-leading team of expert scientists and communicators with deep experience in research and communications, dedicated to inciting change through science. The practice is also at the forefront of thought leadership in the industry, including the publication of Digital Health: Building Social Confidence in Pharma, a study revealing that reluctance, not regulation, is the biggest barrier to social media use in the pharmaceutical industry.